Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 161 entries
Sorted by: Best Match Show Resources per page
Validation of three pain scales among adult postoperative patients in Ghana.

BMC nursing

Aziato L, Dedey F, Marfo K, Asamani JA, Clegg-Lamptey JN.
PMID: 26265901
BMC Nurs. 2015 Aug 11;14:42. doi: 10.1186/s12912-015-0094-6. eCollection 2015.

BACKGROUND: Pain assessment is an important component of pain management and health professionals require valid tools to assess pain to guide their pain management decisions. The study sought to select, develop, and validate context-appropriate unidimensional pain scales for pain...

Cite
Aziato L, Dedey F, Marfo K, et al. Validation of three pain scales among adult postoperative patients in Ghana. BMC Nurs. 2015;14:42doi: 10.1186/s12912-015-0094-6.
Aziato, L., Dedey, F., Marfo, K., Asamani, J. A., & Clegg-Lamptey, J. N. (2015). Validation of three pain scales among adult postoperative patients in Ghana. BMC nursing, 1442. https://doi.org/10.1186/s12912-015-0094-6
Aziato, Lydia, et al. "Validation of three pain scales among adult postoperative patients in Ghana." BMC nursing vol. 14 (2015): 42. doi: https://doi.org/10.1186/s12912-015-0094-6
Aziato L, Dedey F, Marfo K, Asamani JA, Clegg-Lamptey JN. Validation of three pain scales among adult postoperative patients in Ghana. BMC Nurs. 2015 Aug 11;14:42. doi: 10.1186/s12912-015-0094-6. eCollection 2015. PMID: 26265901; PMCID: PMC4531519.
Copy Download .nbib Format: NLM
Validated HPLC determination of 4-dimethylaminoantipyrine in different suppository bases.

Indian journal of pharmaceutical sciences

Kalmár E, Kormányos B, Szakonyi G, Dombi G.
PMID: 24799736
Indian J Pharm Sci. 2014 Jan;76(1):31-7.

Suppositories are important tools for individual therapy, especially in paediatrics, and an instrumental assay method has become necessary for the quality control of dosage units. The aim of this work was to develop a rapid, effective high-performance liquid chromatography...

Cite
Kalmár E, Kormányos B, Szakonyi G, et al. Validated HPLC determination of 4-dimethylaminoantipyrine in different suppository bases. Indian J Pharm Sci. 2014;76(1):31-7
Kalmár, E., Kormányos, B., Szakonyi, G., & Dombi, G. (2014). Validated HPLC determination of 4-dimethylaminoantipyrine in different suppository bases. Indian journal of pharmaceutical sciences, 76(1), 31-7.
Kalmár, E, et al. "Validated HPLC determination of 4-dimethylaminoantipyrine in different suppository bases." Indian journal of pharmaceutical sciences vol. 76,1 (2014): 31-7.
Kalmár E, Kormányos B, Szakonyi G, Dombi G. Validated HPLC determination of 4-dimethylaminoantipyrine in different suppository bases. Indian J Pharm Sci. 2014 Jan;76(1):31-7. PMID: 24799736; PMCID: PMC4007253.
Copy Download .nbib Format: NLM
'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda.

Journal of pharmaceutical policy and practice

Nsabagasani X, Ogwal-Okeng J, Hansen EH, Mbonye A, Muyinda H, Ssengooba F.
PMID: 27280024
J Pharm Policy Pract. 2016 Jun 07;9:22. doi: 10.1186/s40545-016-0071-9. eCollection 2016.

BACKGROUND: The Integrated Management of Childhood Illnesses is the main approach for treating children in more than 100 low income countries worldwide. In 2007, the World Health Assembly urged countries to integrate 'better medicines for children' into their essential...

Cite
Nsabagasani X, Ogwal-Okeng J, Hansen EH, et al. 'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda. J Pharm Policy Pract. 2016;9:22doi: 10.1186/s40545-016-0071-9.
Nsabagasani, X., Ogwal-Okeng, J., Hansen, E. H., Mbonye, A., Muyinda, H., & Ssengooba, F. (2016). 'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda. Journal of pharmaceutical policy and practice, 922. https://doi.org/10.1186/s40545-016-0071-9
Nsabagasani, Xavier, et al. "'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda." Journal of pharmaceutical policy and practice vol. 9 (2016): 22. doi: https://doi.org/10.1186/s40545-016-0071-9
Nsabagasani X, Ogwal-Okeng J, Hansen EH, Mbonye A, Muyinda H, Ssengooba F. 'Better medicines for children' within the Integrated Management of Childhood Illness framework: a qualitative inquiry in Uganda. J Pharm Policy Pract. 2016 Jun 07;9:22. doi: 10.1186/s40545-016-0071-9. eCollection 2016. PMID: 27280024; PMCID: PMC4897804.
Copy Download .nbib Format: NLM
Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach.

Clinical and experimental gastroenterology

Christophi GP, Rengarajan A, Ciorba MA.
PMID: 27274301
Clin Exp Gastroenterol. 2016 May 19;9:125-30. doi: 10.2147/CEG.S80237. eCollection 2016.

Ulcerative colitis (UC) is an immune-mediated disease of the colon that is characterized by diffuse and continuous inflammation contiguous from the rectum. Half of UC patients have inflammation limited to the distal colon (proctitis or proctosigmoiditis) that primarily causes...

Cite
Christophi GP, Rengarajan A, Ciorba MA. Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach. Clin Exp Gastroenterol. 2016;9:125-30doi: 10.2147/CEG.S80237.
Christophi, G. P., Rengarajan, A., & Ciorba, M. A. (2016). Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach. Clinical and experimental gastroenterology, 9125-30. https://doi.org/10.2147/CEG.S80237
Christophi, George P, et al. "Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach." Clinical and experimental gastroenterology vol. 9 (2016): 125-30. doi: https://doi.org/10.2147/CEG.S80237
Christophi GP, Rengarajan A, Ciorba MA. Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach. Clin Exp Gastroenterol. 2016 May 19;9:125-30. doi: 10.2147/CEG.S80237. eCollection 2016. PMID: 27274301; PMCID: PMC4876845.
Copy Download .nbib Format: NLM
Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT.

Iranian journal of reproductive medicine

Davar R, Farid Mojtahedi M, Miraj S.
PMID: 26568750
Iran J Reprod Med. 2015 Aug;13(8):483-8.

BACKGROUND: There is no doubt that luteal phase support is essential to enhance the reproductive outcome in IVF cycles. In addition to progesterone and human chorionic gonadotropin, several studies have described GnRH agonists as luteal phase support to improve...

Cite
Davar R, Farid Mojtahedi M, Miraj S. Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT. Iran J Reprod Med. 2015;13(8):483-8
Davar, R., Farid Mojtahedi, M., & Miraj, S. (2015). Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT. Iranian journal of reproductive medicine, 13(8), 483-8.
Davar, Robab, et al. "Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT." Iranian journal of reproductive medicine vol. 13,8 (2015): 483-8.
Davar R, Farid Mojtahedi M, Miraj S. Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT. Iran J Reprod Med. 2015 Aug;13(8):483-8. PMID: 26568750; PMCID: PMC4637112.
Copy Download .nbib Format: NLM
Diversion Colitis.

Current treatment options in gastroenterology

Eggenberger JC, Farid A.
PMID: 11469982
Curr Treat Options Gastroenterol. 2001 Jun;4(3):255-259. doi: 10.1007/s11938-001-0037-z.

Management of the patient with diversion colitis is dependent upon both patient and disease-related factors. Patients in whom diversion is not permanent, who desire stoma closure, and who have an acceptable surgical risk should undergo re-establishment of intestinal continuity....

Cite
Eggenberger JC, Farid A. Diversion Colitis. Curr Treat Options Gastroenterol. 2001;4(3):255-259doi: 10.1007/s11938-001-0037-z.
Eggenberger, J. C., & Farid, A. (2001). Diversion Colitis. Current treatment options in gastroenterology, 4(3), 255-259. https://doi.org/10.1007/s11938-001-0037-z
Eggenberger, John C., and Farid, Asim. "Diversion Colitis." Current treatment options in gastroenterology vol. 4,3 (2001): 255-259. doi: https://doi.org/10.1007/s11938-001-0037-z
Eggenberger JC, Farid A. Diversion Colitis. Curr Treat Options Gastroenterol. 2001 Jun;4(3):255-259. doi: 10.1007/s11938-001-0037-z. PMID: 11469982.
Copy Download .nbib Format: NLM
Misoprostol in second trimester termination of pregnancy.

Primary care update for Ob/Gyns

Wright-Francis DL, Raynor BD, Webb GW.
PMID: 10838327
Prim Care Update Ob Gyns. 1998 Jul 01;5(4):176. doi: 10.1016/s1068-607x(98)00082-1.

Objective: The purpose of this study is to compare misoprostol to oxytocin and prostaglandin E(2) (PGE(2)) in second trimester termination of pregnancy.Methods: Patients between 14 and 24 weeks gestation scheduled for induction were asked to enroll in the study...

Cite
Wright-Francis DL, Raynor BD, Webb GW. Misoprostol in second trimester termination of pregnancy. Prim Care Update Ob Gyns. 1998;5(4):176doi: 10.1016/s1068-607x(98)00082-1.
Wright-Francis, D. L., Raynor, B. D., & Webb, G. W. (1998). Misoprostol in second trimester termination of pregnancy. Primary care update for Ob/Gyns, 5(4), 176. https://doi.org/10.1016/s1068-607x(98)00082-1
Wright-Francis, et al. "Misoprostol in second trimester termination of pregnancy." Primary care update for Ob/Gyns vol. 5,4 (1998): 176. doi: https://doi.org/10.1016/s1068-607x(98)00082-1
Wright-Francis DL, Raynor BD, Webb GW. Misoprostol in second trimester termination of pregnancy. Prim Care Update Ob Gyns. 1998 Jul 01;5(4):176. doi: 10.1016/s1068-607x(98)00082-1. PMID: 10838327.
Copy Download .nbib Format: NLM
The prophylactic use of diclofenac (Voltarol) suppositories in perineal pain after episiotomy. A random allocation double-blind study.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology

Yoong WC, Biervliet F, Nagrani R.
PMID: 15511762
J Obstet Gynaecol. 1997 Jan;17(1):39-41. doi: 10.1080/01443619750114068.

One hundred and ten patients who had episiotomies to aid normal vaginal delivery without epidural analgesia were = allocated at random to receive either diclofenac (n = 56) or = placebo (n = 54) suppositories. Pain after episiotomy was...

Cite
Yoong WC, Biervliet F, Nagrani R. The prophylactic use of diclofenac (Voltarol) suppositories in perineal pain after episiotomy. A random allocation double-blind study. J Obstet Gynaecol. 1997;17(1):39-41doi: 10.1080/01443619750114068.
Yoong, W. C., Biervliet, F., & Nagrani, R. (1997). The prophylactic use of diclofenac (Voltarol) suppositories in perineal pain after episiotomy. A random allocation double-blind study. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 17(1), 39-41. https://doi.org/10.1080/01443619750114068
Yoong, W C, et al. "The prophylactic use of diclofenac (Voltarol) suppositories in perineal pain after episiotomy. A random allocation double-blind study." Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology vol. 17,1 (1997): 39-41. doi: https://doi.org/10.1080/01443619750114068
Yoong WC, Biervliet F, Nagrani R. The prophylactic use of diclofenac (Voltarol) suppositories in perineal pain after episiotomy. A random allocation double-blind study. J Obstet Gynaecol. 1997 Jan;17(1):39-41. doi: 10.1080/01443619750114068. PMID: 15511762.
Copy Download .nbib Format: NLM
Determination of lidocaine in pharmaceutical preparations using thin-layer chromatographic densitometry.

Journal of pharmaceutical and biomedical analysis

Zivanović L, Zivanov-Stakić D, Radulović D.
PMID: 16867347
J Pharm Biomed Anal. 1988;6(6):809-12. doi: 10.1016/0731-7085(88)80095-5.

A thin-layer chromatographic (TLC)-UV-densitometric method has been developed for the analysis of lidocaine in ointments, suppositories and gels. The method is quantitative, rapid and able to separate lidocaine from other components in the pharmaceutical dosage forms investigated without preliminary...

Cite
Zivanović L, Zivanov-Stakić D, Radulović D. Determination of lidocaine in pharmaceutical preparations using thin-layer chromatographic densitometry. J Pharm Biomed Anal. 1988;6(6):809-12doi: 10.1016/0731-7085(88)80095-5.
Zivanović, L., Zivanov-Stakić, D., & Radulović, D. (1988). Determination of lidocaine in pharmaceutical preparations using thin-layer chromatographic densitometry. Journal of pharmaceutical and biomedical analysis, 6(6), 809-12. https://doi.org/10.1016/0731-7085(88)80095-5
Zivanović, L, et al. "Determination of lidocaine in pharmaceutical preparations using thin-layer chromatographic densitometry." Journal of pharmaceutical and biomedical analysis vol. 6,6 (1988): 809-12. doi: https://doi.org/10.1016/0731-7085(88)80095-5
Zivanović L, Zivanov-Stakić D, Radulović D. Determination of lidocaine in pharmaceutical preparations using thin-layer chromatographic densitometry. J Pharm Biomed Anal. 1988;6(6):809-12. doi: 10.1016/0731-7085(88)80095-5. PMID: 16867347.
Copy Download .nbib Format: NLM
The Spermicidal Powers of Chemical Contraceptives: VI. An Improved Test for Suppositories.

The Journal of hygiene

Baker JR, Ranson RM.
PMID: 20475248
J Hyg (Lond). 1934 Dec;34(4):474-85. doi: 10.1017/s0022172400043254.

No abstract available.

Cite
Baker JR, Ranson RM. The Spermicidal Powers of Chemical Contraceptives: VI. An Improved Test for Suppositories. J Hyg (Lond). 1934;34(4):474-85doi: 10.1017/s0022172400043254.
Baker, J. R., & Ranson, R. M. (1934). The Spermicidal Powers of Chemical Contraceptives: VI. An Improved Test for Suppositories. The Journal of hygiene, 34(4), 474-85. https://doi.org/10.1017/s0022172400043254
Baker, J R, and Ranson, R M. "The Spermicidal Powers of Chemical Contraceptives: VI. An Improved Test for Suppositories." The Journal of hygiene vol. 34,4 (1934): 474-85. doi: https://doi.org/10.1017/s0022172400043254
Baker JR, Ranson RM. The Spermicidal Powers of Chemical Contraceptives: VI. An Improved Test for Suppositories. J Hyg (Lond). 1934 Dec;34(4):474-85. doi: 10.1017/s0022172400043254. PMID: 20475248; PMCID: PMC2170904.
Copy Download .nbib Format: NLM
STUDIES ON THE ABSORPTION OF SULFANILAMIDE FROM THE LARGE INTESTINE: RESULTS FOLLOWING THE ADMINISTRATION OF SUPPOSITORIES.

Annals of surgery

Turell R, Marino AW, Nerb L.
PMID: 17857650
Ann Surg. 1940 Sep;112(3):417-20. doi: 10.1097/00000658-194009000-00009.

No abstract available.

Cite
Turell R, Marino AW, Nerb L. STUDIES ON THE ABSORPTION OF SULFANILAMIDE FROM THE LARGE INTESTINE: RESULTS FOLLOWING THE ADMINISTRATION OF SUPPOSITORIES. Ann Surg. 1940;112(3):417-20doi: 10.1097/00000658-194009000-00009.
Turell, R., Marino, A. W., & Nerb, L. (1940). STUDIES ON THE ABSORPTION OF SULFANILAMIDE FROM THE LARGE INTESTINE: RESULTS FOLLOWING THE ADMINISTRATION OF SUPPOSITORIES. Annals of surgery, 112(3), 417-20. https://doi.org/10.1097/00000658-194009000-00009
Turell, R, et al. "STUDIES ON THE ABSORPTION OF SULFANILAMIDE FROM THE LARGE INTESTINE: RESULTS FOLLOWING THE ADMINISTRATION OF SUPPOSITORIES." Annals of surgery vol. 112,3 (1940): 417-20. doi: https://doi.org/10.1097/00000658-194009000-00009
Turell R, Marino AW, Nerb L. STUDIES ON THE ABSORPTION OF SULFANILAMIDE FROM THE LARGE INTESTINE: RESULTS FOLLOWING THE ADMINISTRATION OF SUPPOSITORIES. Ann Surg. 1940 Sep;112(3):417-20. doi: 10.1097/00000658-194009000-00009. PMID: 17857650; PMCID: PMC1387969.
Copy Download .nbib Format: NLM
Erectile preservation following radical prostatectomy.

Therapeutic advances in urology

Segal R, Burnett AL.
PMID: 21789097
Ther Adv Urol. 2011 Feb;3(1):35-46. doi: 10.1177/1756287211400492.

Prostate cancer is the most common cancer among men, representing approximately 25% of all new cancer diagnoses in the USA. For clinically localized prostate cancer, the gold standard for therapy remains radical prostatectomy. One of the main adverse effects...

Cite
Segal R, Burnett AL. Erectile preservation following radical prostatectomy. Ther Adv Urol. 2011;3(1):35-46doi: 10.1177/1756287211400492.
Segal, R., & Burnett, A. L. (2011). Erectile preservation following radical prostatectomy. Therapeutic advances in urology, 3(1), 35-46. https://doi.org/10.1177/1756287211400492
Segal, Robert, and Burnett, Arthur L. "Erectile preservation following radical prostatectomy." Therapeutic advances in urology vol. 3,1 (2011): 35-46. doi: https://doi.org/10.1177/1756287211400492
Segal R, Burnett AL. Erectile preservation following radical prostatectomy. Ther Adv Urol. 2011 Feb;3(1):35-46. doi: 10.1177/1756287211400492. PMID: 21789097; PMCID: PMC3126086.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 161 entries